Modernization Of Chinese Medicine Research Articles

Research progress in simultaneous detection of mycotoxins in traditional Chinese medicine

Mycotoxins, as secondary metabolites of fungi, have become key risk factors in Chinese medicinal materials. There are risks of fungal contamination and mycotoxin induced in the process of natural growth or artificial planting of Chinese medicinal materials to clinical use. The common mycotoxins in traditional Chinese medicine and the synchronous detection methods of various mycotoxins in modern Chinese medicine were reviewed in order to further understand the relevant standards of mycotoxins in traditional Chinese medicine, so as to improve the quality of Chinese medicinal materials and safeguard human safety and health.

Study on The Treatment of Osteonecrosis of The Femoral Head Based on The Classic Theory of “Blood Stasis Removal - Regeneration Bone - Fusion”

Objective Based on Traditional Chinese Medicine (TCM) classics, this paper, by searching the literature on the treatment of femoral head necrosis with TCM, aims to explain the essence of the theory of “blood stasis removal - regeneration bone - fusion”, analyze the development of modern Chinese medicine in the treatment of osteonecrosis of femoral head (ONFH), and provide new ideas for the treatment of ONFH with integrated traditional Chinese and western medicine. Methods CNKI, PubMed, Wanfang and VIP databases were searched by computer to collect literature research on the theory of “blood stasis removal - regeneration bone - fusion” and the treatment of ONFH with integrated TCM Western medicine. Based on content analysis and bibliometric analysis, the modern integrated traditional Chinese and western medicine literature database of treating ONFH with the theory of “removing blood stasis and generating bone” was established and analyzed. Results Based on the theory of “blood stasis removal - regeneration - bone fusion”, this paper found that the TCM treatment of ONFH has the clinical effect of promoting blood circulation and removing blood stasis. The essence of the modern medicine of the theory of “blood stasis removal - regeneration - bone fusion” is to eliminate the microcirculation disorders caused by microvascular regeneration and hypoperfusion, so as to promote bone regeneration, which coincides with the treatment of ONFH by western medicine. Conclusions The theory of “blood stasis removal - regeneration - bone fusion” in modern Chinese medicine has a certain scientific and valuable value, which is worth more scientific research in the future.

Retracted: Data Mining-Based Analysis of Modern Chinese Medicine for the Treatment of Stable Angina Pectoris in Coronary Heart Disease.

[This retracts the article DOI: 10.1155/2022/3511974.].

Chinese Medicine as Supporting Therapy for Psoriasis: Past, Present, and Future.

Psoriasis is a chronic skin disease and an important health concern. Western medicine and therapies are the main treatment strategies for psoriasis vulgaris (PV); however, the overall prognosis of patients with PV is still poor. Therefore, PV prevention is especially crucial. Chinese medicine (CM) has a long history of treating psoriasis, and it has unique wisdom in different cognitive angles and treatment modes from modern medicine. In this review, we first summarized the herbs and ancient CM formulas that have therapeutic effects on PV. Second, the research status and obstacles to the current development of CM in modern medicine were reviewed. Finally, the future of CM in the context of precision medicine and integrated medicine was discussed. After a detailed reading of the abundant literature, we believe that CM, through thousands of years of continuous development and clinical practice, has achieved high effectiveness and safety for PV treatment, despite its surrounding controversy. Moreover, precise analyses and systematic research methods have provided new approaches for the modernization of CM in the future. The treatment of PV with CM is worth popularizing, and we hope it can benefit more patients.

Theoretical innovation of component-based Chinese medicine and its exemplary practice: the study on creating Guanxinning Tablets

Upholding the wisdom of traditional Chinese medicine that the therapeutic principle, method, formula and medicine are coherent with each other, we propose the technical methodology for intelligent creation of component-based Chinese medicine by integrating multidisciplinary knowledge such as artificial intelligence, pharmaceutical informatics, system pharmacology and phytochemistry. Taking the creation of Guanxinning Tablets as an example, we expound the technical principle for creating component-based Chinese medicine and briefly describe the design method for optimizing the entity of Chinese medicine efficacy by rational combination of active components. Our research sought to "clarify and explain" the mechanism of its clinical treatment action through multi-modal and multi-scale systematic pharmacology studies. This work emphatically demonstrates the pilot workshop and engineering validation platform based on the intelligent simulation of whole production process, and outlines the design principles of the intelligent production line for innovative Chinese medicine. The results of industrial research show that the ourself established method for evaluating the process quality controllability and intelligent production line can be applied to manufacturing Guanxining Tablets with high quality. Through the innovative research of multidisciplinary cross-border integration, the present work explored a new way for the creation of modern Chinese medicine.

A randomized double-blind controlled study protocol on the efficacy and safety of Sangdantongluo granule in the treatment of post-stroke spasticity

IntroductionStroke is the first leading cause of mortality and disability worldwide, and post-stroke spasticity (PSS) is the common complication of stroke. Sangdantongluo Granule (Z20210481000), a modern patent Chinese medicine, is widely used in clinical practice to treat PSS. Whereas, there is limited evidence of effectiveness for Sangdantongluo Granule to treat PSS. This study will evaluate the clinical efficacy and safety of Sangdantongluo granule in the treatment of PSS. Methodsand Analysis This multicenter, randomized, double-blind and placebo-controlled study will recruit 132 participants in China who develops PSS 15 days–90 days after stroke. Participants will be randomly assigned in an equal ratio to receive either Sangdantongluo granule or placebo for 2 months twice a day orally. The primary measure is the Modified Ashworth Scale (MAS), Secondary outcome measures include Composite Spasticity Scale (CSS), Simplified Fugl-Meyer Motor Scale (S-FM), National Institute of Health stroke scale (NIHSS), Modified Rankin Scale (mRS), Modified Barther Index (MBI), and Surface electromyography. Adverse events will be supervised throughout the trial. SPSS V. 26.0 statistical software will be used for statistical analysis. Enrolment will be started in April 2022. Ethics and disseminationThe trial and protocol were approved by the Ethics Committee of Hunan Academy of Chinese Medicine Affiliated Hospital (No. [202102]20). We will report the results of this trial in a peer-reviewed journal. Trial registrationClinicalTrials.gov ChiCTR2100044544. Registered on 23 March 2021.

Integrating network pharmacology and in vivo experimental validation to reveal the alleviation of mailuoning oral liquid on non-alcoholic fatty liver disease

BackgroundNon-alcoholic fatty liver disease (NAFLD) especially the later stage non-alcoholic steatohepatitis (NASH) seriously endangers human's health and has become a global public health issue in recent years. Mailuoning Oral Liquid (MLN) is a modern traditional Chinese medicine prescription composed by Lonicerae japonicae flos, Achyranthis bidentatae radix, Scrophulariae radix and Dendrobium Caulis. MLN is generally used to treat the syndrome of blood stasis in clinical practice. PurposeTo observe the alleviation of MLN on NASH in vivo, and explore the possible underlying mechanism. Furthermore, this study also aims to find which Chinese medicinal drug contained in MLN exerts the main pharmacological activity. MethodsNASH model was induced in mice by feeding with methionine and choline deficient (MCD) diet. The effects of MLN on hepatic lipids accumulation, liver inflammation, hepatic fibrosis, and the expression of some molecules were investigated by histological observation, biochemical index analysis, quantitative real-time PCR and western blot. Network pharmacology was applied to predict those involved molecular targets and potential mechanisms, which was further validated in vivo. BODIPY fluorescence staining assay was used to detect cellular lipids accumulation. ResultsMLN (7.8, 23.4 ml/kg) improved NASH in MCD-fed mice. Network pharmacology results demonstrated that peroxisome proliferator-activated receptor α (PPARα) signaling pathway was crucially involved in the MLN-provided alleviation on NASH. Further experimental validation results showed that MLN increased the expression of peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α) and restored the decreased expression of nuclear PPARα in MCD-fed mice. Further results displayed that Achyranthis bidentatae radix and Lonicerae japonicae flos contributed greatly to the MLN-provided alleviation on NASH in vivo. BODIPY fluorescence staining assay showed that 25R-inokosterone and cynaroside, two compounds from Achyranthis bidentatae radix and Lonicerae japonicae flos, obviously reduced intracellular lipids accumulation in hepatocytes stimulated by non-esterified fatty acid (NEFA). ConclusionMLN improved NASH in MCD-fed mice, and the PGC-1α-PPARα signaling pathway was involved in this process. Moreover, Lonicerae japonicae flos and Achyranthis bidentatae radix contained in MLN contributed greatly to the MLN-provided improvement on NASH.

Potential Material Basis of Yupingfeng Powder for the Prevention and Treatment of 2019 Novel Coronavirus Pneumonia: A Study Involving Molecular Docking and Molecular Dynamic Simulation Technology.

Objective In this study, we investigated the potential material basis of Yupingfeng powder in the prevention and treatment of 2019 novel coronavirus pneumonia (NCP) by applying molecular docking and molecular dynamic simulation technology. Design The active ingredients and predictive targets of Yupingfeng powder were sourced using the TCMSP, ETCM, and TCMIP traditional Chinese medicine databases. NCP-related targets were then acquired from the DisGeNET and GeneCards databases, and common disease-drug targets were imported into the STRING database, and Cytoscape software was used to generate a protein-protein interaction network following the use of a network topology algorithm to identify key target genes. Gene Ontology (GO) and KEGG pathway enrichment analysis was then performed using the target genes and GOEAST and DAVID online tools. The mechanism of Yupingfeng powder in the prevention and treatment of NCP was analyzed with reference to the relevant literature. AutoDock software was used for molecular docking, the preliminary analysis of binding status, and to identify the best conformation. Desmond software was used to perform molecular dynamic simulations for protein and compound complexes, perform free energy calculations and hydrogen bond analysis, and to further verify the binding mode. Results Overall, 38 main active components and 218 predictive targets of Yupingfeng powder were identified and 298 disease targets related to NCP were retrieved from disease databases. Yupingfeng powder was found to act predominantly on the TNF, Toll-like receptor, HIF-1, NOD-like receptor, cytokine-receptor interaction, MAPK, T cell receptor, and VEGF signaling pathways. Molecular docking of the three selected key active components with the 3CL-like protease (3CL-Pro) of SARS-CoV-2 showed that they each had a strong binding force and good affinity. Conclusions Yupingfeng powder primarily acts on multiple active ingredients and potential targets through multiple action channels and signal pathways. Molecular docking and molecular dynamic simulation technology were used to effectively predict and analyze the potential mechanism by which this Chinese medicine can combat NCP. These results provide a reference for developing new modern Chinese medicine preparations against NCP in the future.

Analysis of Chinese Medicine Compound in Treatment of Urticaria with Rheumatic Fever

Purpose: To explore the rules of prescriptions of modern clinical Chinese medicine compound prescriptions in treatment of urticaria with rheumatic fever, and to provide a reference for the clinical treatment. Methods: The literature on the treatment of urticaria with rheumatic fever with medicine compound prescriptions from October 1st, 1949 to January 1st, 2021 in China National Knowledge Infrastructure (CNKI) was searched to establish an Excel database of medicine prescriptions, and data analysis was performed by SPSS Statistics22.0 and SPSS Modeler18.0. Results: A total of 52 articles are included in this study, involving 54 medicine prescriptions and 97 Chinese medicines with a cumulative frequency of 623 times. Among them, 39 Chinese medicines are used more than 4 times, with the highest frequency of Fangfeng. They are mainly pungent, cold in nature, with the channel tropism of liver and lung. There are 19 second-order association rules for mining TCM association rules, with the first five rules ranked in the descending order of confidence as follows: Fangfeng + Scutellaria baicalensis, Jingjie + Anemarrhenae Rhizoma, Fangfeng + Anemarrhenae rhizoma, Fangfeng + Arctium fruit, Fangfeng + Jingjie, with 103 third-order associations and 124 fourth-order associations, which are consistent with the actual clinical application. Conclusion: The modern clinical treatment of urticaria with rheumatic fever is based on "dispelling wind to relieve exterior syndrome", and also on "curing deficiency", "resolving dampness", "suppressing hyperactive liver for calming endogenous wind", and "promoting blood circulation and removing blood stasis". The data provides reference for the clinical treatment of the disease and Chinese medicine research.

The Therapeutic Effect and Mechanism of Qishen Yiqi Dripping Pills on Cardiovascular and Cerebrovascular Diseases and Diabetic Complications.

The alterations in vascular homeostasis are deeply involved in the development of numerous diseases, such as coronary heart disease, stroke, and diabetic complications. Changes in blood flow and endothelial permeability caused by vascular dysfunction are the common mechanisms for these three types of diseases. The disorders of glucose and lipid metabolism can bring changes in the energy production patterns in endothelium and surrounding cells which may consequently cause energy metabolic disorders, oxidative stress, and inflammatory responses. Traditional Chinese medicine (TCM) follows the principle of the "treatment by the syndrome differentiation." TCM considers coronary heart disease, stroke, and diabetes complications all as the type of Qi-deficiency and blood stasis syndrome, which mainly occurs in the vascular system. Therefore, the common pathogenesis of these three types of diseases suggests that the treatment strategy by TCM should be in a close manner and referred to as "treating different diseases by the same treatment." Qishen Yiqi dripping pill is a modern Chinese herbal medicine that has been widely used for the treatment of patients with coronary heart disease characterized as Qi-deficiency and blood stasis in China. Recently, many clinical reports have demonstrated the potential therapeutic effects of Qishen Yiqi dripping pills on ischemic stroke and diabetic nephropathy. Based on these reports, we will summarize the clinical applications of Qishen Yiqi dripping pills on coronary heart disease, ischemic stroke, and diabetic nephropathy, including the involved mechanisms discussed in various research works.

Mechanism of Guanxinning against cerebral ischemia-reperfusion injury in mice based on transcriptomic analysis

Guanxinning, a modern Chinese medicine preparation composed of Salviae Miltiorrhizae Radix et Rhizoma and Chuanxiong Rhizoma, has the activities of activating blood circulation, resolving blood stasis, dredging vessels, and nourishing the heart. Clinical studies have demonstrated that Guanxinning has therapeutic effect on ischemic stroke, while the specific mechanism remains to be clarified. In this study, the potential mechanism of Guanxinning against cerebral ischemia-reperfusion injury in mice was explored and then verified in vitro. The mouse model of cerebral ischemia-reperfusion injury was established with middle cerebral artery embolization(MCAO) method. The pharmacological effects of Guanxinning on the model mice were investigated based on neurological function score, cerebral infarction area, pathological morphology, neuron injury, and apoptosis. The results showed that Guanxinning lowered neurological functional score, reduced cerebral infarction area, and ameliorated the histopathological morphology, neuronal damage, and apoptosis in the model mice. RNA samples were extracted from brain tissues and subjected to RNA sequencing(RNA-seq). The differentially expressed genes(DEGs) were screened with the thresholds of ■. GO function enrichment analysis and KEGG pathway enrichment analysis were performed for the 297 common DEGs, which indicated that Guanxinning may regulate the inflammatory response, oxidative stress response, energy metabolism, and apoptosis to treat cerebral ischemia-reperfusion injury in mice. Guanxinning exerted protective effect through inhibiting inflammation and reducing oxidative stress in hypoxia/reoxygenation injured SH-SY5 Y cells. Furthermore, Western blot indicated that Guanxinning down-regulated the protein levels of p-NF-κB p65 and p-p38 MAPK and up-regulated those of PPARγ and PGC-1α. The findings suggested that Guanxinning may inhibit inflammation and reduce oxidative stress by suppressing TNF signaling pathway and activating PPAR signaling pathway, thereby exerting the therapeutic effect on cerebral ischemia-reperfusion injury in mice. This study preliminarily reveals the mechanism of Guanxinning against cerebral ischemia-reperfusion injury and provides a basis for clinical application of Guanxinning.

Guiding significance of "disease-syndrome-symptom" mode in FU Qing-zhu's Obstetrics and Gynecology (FU Qing-zhu Nyu Ke) for dealing with ovulation disorder infertility caused by hyperprolactinemia

This paper discussed the guiding significance of "disease-syndrome-symptom" mode in FU Qing-zhu's Obstetrics and Gynecology(FU Qing-zhu Nyu Ke) for dealing with ovulation disorder infertility caused by hyperprolactinemia(HPRL). FU Qing-zhu's Obstetrics and Gynecology(FU Qing-zhu Nyu Ke) concentrates on the disease entities, main symptoms, pathogenesis, and syndrome differentiation, based on which the prescriptions are prescribed. This reflects the "disease-syndrome-symptom" mode, with the core lying in the "combination of disease with syndrome". The contained Discussion on Menstruation Regulation(Tiao Jing Pian) and Discussion on Getting Pregnant(Zhong Zi Pian) have important reference significance for later doctors in the diagnosis and treatment of inferti-lity, and many prescriptions are still in use due to good effects. It is believed in traditional Chinese medicine(TCM) that HPRL results from kidney deficiency and liver depression, among which kidney deficiency is the main cause. Liver depression accelerates the onset of HPRL, so the kidney-tonifying and liver-soothing herbs were mainly selected. The "disease-syndrome-symptom" mode in FU Qing-zhu's Obstetrics and Gynecology(FU Qing-zhu Nyu Ke) sheds enlightenment on the diagnosis and treatment of ovulation infertility caused by HPRL, in that it is not confined to disease entity and syndrome type. The integration of "disease-syndrome-symptom" highlights the main complaint of patients and emphasizes the main pathogenesis, thus giving full play to the overall advantage of syndrome differentiation. For multiple diseases in FU Qing-zhu's Obstetrics and Gynecology(FU Qing-zhu Nyu Ke) such as infertility due to liver depression, infertility due to obesity, delayed menstruation, and irregular menstruation, although the typical lactation symptom of HPRL is not mentioned, the medication can still be determined according to the chief complaint, syndrome type, and symptoms and signs, making up for the defects of excessive reliance on serum biochemical indicators in modern Chinese medicine. We should learn its diagnosis and treatment thoughts of paying attention to liver, spleen, kidney, and heart, holism, and strengthening body resistance to eliminate pathogenic factors.

Data Mining-Based Analysis of Modern Chinese Medicine for the Treatment of Stable Angina Pectoris in Coronary Heart Disease.

The aim of this study is to explore the clinical effects of Chinese medicine in the treatment of stable angina pectoris in coronary heart disease. Chinese medicine has multitarget, multilevel, and multilink effects in the treatment of coronary angina, which can significantly improve patients' symptoms. Its mechanism of action involves multiple levels such as regulating lipid metabolism, improving platelet function, antioxidant, and protecting endothelial function. The design was based on data mining to analyse the dosing pattern of modern Chinese medicine for the treatment of stable angina pectoris in coronary heart disease. The number of episodes of angina pectoris, the duration of the episodes, and the changes in the electrocardiogram before and after taking the medicine were observed and compared between the two groups. The number and duration of angina attacks ((2.23 ± 0.77) per week and (1.31 ± 0.34) min/time, respectively) in the study group were found to be significantly better than those in the control group ((3.86 ± 1.03) per week and (2.46 ± 1.21) min/time, respectively).

Quantification of "Cold-Hot" Medicinal Properties of Chinese Medicines Based on Primary Metabolites and Fisher's Analysis.

Background Chinese medicinal properties (CMP) are an important part of the basic theory of traditional Chinese medicines (TCMs). Quantitative research on the properties of TCMs is of great significance to deepen the understanding and application of the theory of drug properties and promoting the modernization of TCMs. However, these studies are limited to strong subjectivity or distinguish different drug properties based on certain indicators since CMP studies are diverse. Objective To realize quantitative comparison of same medicinal properties of different Chinese medicines. Method To solve the above problem, we proposed and explored quantification of Chinese medicinal properties (QMP) and the quantification value of medicinal properties “R”. The correlation between primary metabolites and “cold-hot” medicinal properties was explored on the premise of material basis of Chinese herbal medicines and Fisher's analysis. Based on indicators related to “cold-hot” medicinal properties, we utilized quantitative values “R” to characterize the strength or weakness of “cold-hot” medicinal properties. Results According to QMP, the same medicinal properties were quantified and compared by quantification value of medicinal properties that expressed by alphabet “R”. The general theoretical formula of “R” deduced is R = (‖l‖ × cos θ)/‖L‖ = ∑i=1njipi/∑i=1npi2, in which n ≥ 1. In the light of formula of “R” and indicators related to “cold-hot” medicinal properties, we got “R” value of “cold-cool” and “warm-hot” medicinal properties. “R” values of “cold-cool” medicinal properties of Phellodendri chinensis cortex, Coptidis rhizoma, and Menthae haplocalycis herba were 0.63, 1.00, and 0.49, respectively. The result showed that Coptidis rhizoma is the most “cold-cool”, followed by Phellodendri chinensis cortex, with Menthae haplocalycis herba is the weakest in the three Chinese medicines, consistent with cognition of TCM theory. Conclusion QMP has certain guiding significance for the quantification of “cold and hot” drug properties. “R” is feasible to realize the quantitative comparison of the same drug properties of different traditional Chinese medicine, which is helpful to promote process of modern Chinese medicine construction.

Construction of quality evaluation strategy for Chinese medicine based on ambient mass spectrometry

Quality is the guarantee for the clinical safety and effectiveness of Chinese medicine. Accurate quality evaluation is the key to the standardization and modernization of Chinese medicine. Efforts have been made in improving Chinese medicine quality and strengthening the quality and safety supervision in China, but rapid and accurate quality evaluation of complex Chinese medicine samples is still a challenge. On the basis of the development of ambient mass spectrometry and the application in quality evaluation of complex Chinese medicine systems in recent years, the authors developed the multi-scenario Chinese medicine quality evaluation strategies. A systematic methodology was proposed in specific areas such as real-time monitoring of the quality of complex Chinese medicine decoction system, rapid toxicity grading of compound Chinese patent medicine, and evaluation of bulk medicinals of Chinese patent medicine. Allowing multi-scenario analysis of Chinese medicine, it is expected to provide universal research ideas and technical methods for rapid and accurate quality evaluation of Chinese medicine and boost the high-quality development of Chinese medicine industry.

Analysis of Prescription Rules of Neonatal Jaundice in 'Yibu Quanlu' Based on Data Mining

Objective: To analyze the prescription rules for the treatment of neonatal jaundice in 'Yibu Quanlu' based on data mining technology. Methods: The provisions of the treatment of neonatal jaundice recorded in the 'Yibu Quanlu' were collected. Through the collation and entry of the ancient and modern medical case cloud platform, the data included in the medical case were standardized, and then the standardized prescription database was generated. Finally, the data analysis module in the platform was used to process the frequency statistics, association rule analysis, cluster analysis and complex network analysis of traditional Chinese medicine. Results: Included in 57 provisions (including 6 ancient medical cases), 67 prescriptions of traditional Chinese medicine, involving 112 herbs, the cumulative frequency of 751 times. The highest frequency of use of traditional Chinese medicine is licorice, followed by atractylodes, the average dose of traditional Chinese medicine is Yinchen; the taste is mainly bitter cold, followed by Ganping; most of them belong to the spleen, stomach and lung meridians. The use of moisturizing drugs is the most, followed by tonifying drugs; the Chinese herbal pair with the highest support was Poria – Atractylodes macrocephala; core Chinese medicine prescription is Yinchen Wuling Powder and Yigong Powder. Conclusion: A comprehensive analysis of prescription and medication rules for treating neonatal jaundice in 'Yibu Quanlu', and finds that clearing heat and removing dampness, protecting spleen and stomach, and preventing transmission become the main guiding ideology for the diagnosis and treatment of this disease. Eliminating pathogenic factors and strengthening vital energy are the main characteristics of prescription medication for ancient doctors. This study can provide new ideas for the clinical diagnosis and treatment of neonatal jaundice in modern Chinese medicine and the development of new drugs.

The Fertility Culture in Chinese Characters from the Medical Point of View

In this paper,9 Chinese characters related to fertility culture are listed and analyzed from three aspects: gestate of life, birth of life and upbringing of life. Combined with the research of ancient and modern Chinese and western medicine, the definition of Chinese characters composition and evolution is further enriched.

Research on the Development of Chinese Medicine and Its Impact on the Environment

Traditional Chinese medicine has been among the two major drug systems in the world since ancient times and has played a very important role in the medical industry. With the development of traditional Chinese medicine, while the efficacy of medicine has been improved, it has gradually had a huge impact on the surrounding environment. The reduction of environmental quality not only affects the quality of traditional Chinese medicine but also causes harm to other organisms. Therefore, it is extremely important to improve the production methods of traditional Chinese medicine. Based on the different production methods of different types of traditional Chinese medicines, the improvement methods are also different. This paper mainly studies the influence of environmental factors on the quality of Chinese herbal medicine and the influence of the industrialization of modern Chinese medicine on the surrounding environment and the solutions. By referring to the relevant literature on traditional Chinese medicine, the problems existing in the whole process from raw materials to the processing of traditional Chinese medicine are analyzed to find corresponding solutions. Through the research of this paper, it is found that although traditional Chinese medicine has some influence on the surrounding environment in the process of industrialization, the improvement of the curative effect of the medicine is still obvious, and it has made a huge contribution to the improvement of the national health level.

Gaps and feasibility of fixed-dose combination strategy in the development of modern Chinese medicine

Gaps and feasibility of fixed-dose combination strategy in the development of modern Chinese medicine

Construction of pharmacophore model and its application in identification of effective components of Chinese medicine

The effective material basis of Chinese medicine is the key and difficult point in the quality control and modernization research of Chinese medicine. With the increasing application of pharmacophore-based virtual screening in computer-aided drug design, it is possible to employ this technology in the modernization of Chinese medicine. Based on the systematic research method of the pharmacophore model, the present study systematically reviewed the pharmacophore-based technologies and strategies in the identification of active components in Chinese medicine.